Clinical Significance of Expression of Estrogen Receptor α and β mRNAs in Ovarian Cancers

Publisher： Karger

E-ISSN： 1423-0232|58|4|334-341

ISSN： 0030-2414

Source： Oncology, Vol.58, Iss.4, 2000-05, pp. : 334-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Implications of the Expression of Estrogen Receptor-α and -β in Primary and Metastatic Lesions of Uterine Endometrial Cancers

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 269-277

Karger

Access to resources Recommend Favorite

Identification of Exon-Deleted Progesterone Receptor mRNAs in Human Uterine Endometrial Cancers

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 60-65

Karger

Access to resources Recommend Favorite

Quantitative Analysis of Estrogen Receptor-α and -β Messenger RNA Expression in Normal and Malignant Thyroid Tissues by Real-Time Polymerase Chain Reaction

By  

Oncology, Vol. 61, Iss. 4, 2001-11 ,pp. : 293-298

Karger

Access to resources Recommend Favorite

Estrogen receptor β transcript variants associate with oncogene expression in endometrial cancer

By                

International Journal of Molecular Medicine, Vol. 29, Iss. 6, 2012-01 ,pp. : 1127-1136

Spandidos Publications

Access to resources Recommend Favorite

Clinical Implications of Expression of ETS-1 Related to Angiogenesis in Metastatic Lesions of Ovarian Cancers

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 420-428

Karger

Access to resources Recommend Favorite